Skip to search formSkip to main contentSkip to account menu

Lisinopril

Known as: N2-[(1S)-1-Carboxy-3-phenylpropyl]-L-lysyl-L-proline, Dihydrate, (S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline, [N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline 
An orally bioavailable, long-acting angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. Lisinopril, a synthetic peptide… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
To compare the effects of three antihypertensive medications on cerebral hemodynamic and cognitive function in hypertensive… 
Highly Cited
2000
Highly Cited
2000
OBJECTIVE To compare the long-term effect on kidney function of a long-acting calcium antagonist (nisoldipine) versus a long… 
Highly Cited
1999
Highly Cited
1999
In this study, telmisartan, a new angiotensin AT ( 1 ) receptor antagonist given as monotherapy and in combination with… 
Highly Cited
1999
Highly Cited
1999
Dry cough is a troublesome side‐effect associated with certain antihypertensive agents that act by modulating aspects of the… 
Highly Cited
1997
Highly Cited
1997
The present study compares the occurrence of a dry, persistent cough with doses of 80 mg of valsartan, 10 mg of lisinopril, or 25… 
Highly Cited
1990
Highly Cited
1990
Excerpt Recent studies in hypertensive, diabetic rats have shown that angiotensin-converting enzyme inhibitors reduce urinary…